Clinical adjudication in GLP-1 and other weight loss treatment trials | The link between diabetes research and obesity innovation
Due to the rising global prevalence of diabetes, particularly Type 2, diabetes research has seen a significant increase in funding, investment, and resource allocation in recent years. Such investment has led to a number of milestone approvals, notably including those for GLP-1 receptor agonists. Glucagon-like peptide-1 (GLP-1) agonists are a novel class of medication which works […]